GSRX Industries Inc. Receives Establishment License for New Green Spirit RX Medicinal Cannabis Dispensary by Department of Health of Puerto Rico
Fifth Green Spirit RX Dispensary to Begin Retail Operations in Fajardo
DORADO, Puerto Rico, Dec. 27, 2018 (GLOBE
NEWSWIRE) -- GSRX Industries Inc. (GSRX)
(“GSRX†or, the “Companyâ€), through its wholly-owned subsidiary,
Project 1493 LLC, has received the establishment license for the
Company’s newest Green Spirit RX medicinal cannabis dispensary in
Puerto Rico, clearing the way for the dispensary to begin retail
operations immediately.
The newest Green Spirit RX medicinal cannabis dispensary is located at Bo. Quebrada de Fajardo, Carr. #3 Km. 44.9. At nearly 5,000 square feet, GSRX’s Fajardo medicinal cannabis dispensary will be one of the island’s largest. Upon opening, it will become the Company’s fifth medicinal cannabis dispensary in Puerto Rico.
An ocean side community, Fajardo is home to the
largest marina in the Caribbean, Puerto del Rey, which is a hub for
the majority of Puerto Rico’s recreational boating, and a popular
launching port for nearby Vieques, Culebra, and the U.S. and
British Virgin Islands. Fajardo is popular among tourists,
and its beaches are bounded by calm, clear waters ideal for
snorkeling. It is also home to one of the few bioluminescent
lagoons in the world, with nightly kayak trips offered by local
companies who give educational tours. Fajardo is also home to
the Waldorf Astoria’s world-class spa and resort, the El
Conquistador.
GSRX currently operates four other Green Spirit RX dispensaries in
Puerto Rico, with locations in Dorado, Carolina, and two in San
Juan (Andalucia and Hato Rey). The Company has pre-qualified
licenses for four additional locations in Isla Verde, Bayamón, Old
San Juan, and Guaynabo. GSRX holds pre-qualified licenses in
Puerto Rico for cannabis manufacturing and transportation, which
allows for at-home patient delivery.
About GSRX Industries
Inc.
GSRX Industries Inc. (GSRX), through its subsidiaries, is in the
business of acquiring, developing and operating retail cannabis
dispensaries, and is in the process of expanding its business to
include the cultivation, extraction, manufacture and delivery of
cannabis and cannabinoid products. Currently, GSRX
operates four cannabis dispensaries in Puerto Rico, with another
(Fajardo) pending opening, operates one dispensary in California,
and has four additional pre-qualified locations in Puerto Rico, all
of which are in various phases of development and construction.
Websites:
Green Spirit RX https://www.greenspiritrx.com/
Spirulinex https://www.spirulinex.com
Instagram:
Spirulinex https://www.instagram.com/spirulinex/
The Green Room https://www.instagram.com/greenroommendo/
Facebook:
Green Spirit RX (Puerto Rico) https://www.facebook.com/Green-Spirit-Rx-746194692378429/
Spirulinex https://www.facebook.com/spirulinex/
The Green Room https://www.facebook.com/greenroommendo/
Forward-Looking Statements
This press release
contains forward-looking statements. Such statements include
statements regarding our expectations, hopes, beliefs or intentions
regarding the future, including but not limited to statements
regarding our market, strategy, competition, development plans
(including acquisitions and expansion), financing, revenues,
operations, and compliance with applicable laws. Forward-looking
statements involve certain risks and uncertainties, and actual
results may differ materially from those discussed in any such
statement. Factors that could cause actual results to differ
materially from such forward-looking statements include the risks
described in greater detail in the following paragraphs. All
forward-looking statements in this document are made as of the date
hereof, based on information available to us as of the date hereof,
and we assume no obligation to update any forward-looking statement
except where applicable law requires us to update these statements.
Market data used throughout this prospectus is based on published
third party reports or the good faith estimates of management,
which estimates are based upon their review of internal surveys,
independent industry publications and other publicly available
information.
